StageZero Life Sciences

StageZero Life Sciences is dedicated to the early detection of cancer and multiple disease states through whole blood. The next-generation test by StageZero Life Sciences, Aristotle®, is a multi-cancer panel that screens for 10 cancers simultaneously from a single blood sample, with high sensitivity and specificity for each cancer. Based on our proprietary mRNA technology platform, which has been validated on 10,000 patients and used to develop the first liquid biopsy for colorectal cancer.